Cassava Sciences Inc (NASDAQ:SAVA) does about 5.04M shares in volume on a normal day but saw 3084819 shares change hands in the recent trading day. The company now has a market cap of 126.14M USD. Its current market price is $2.66, marking a decrease of -3.27% compared to the previous close of $2.75. The 52 week high reached by this stock is $42.20 whilst the lowest price level in 52 weeks is $2.69.
Cassava Sciences Inc (SAVA) has a 20-day trading average at $9.48 and the current price is -93.70% off the 52-week high compared with -1.12% distance from its 52-week low. The 50-day simple moving average of the closing price is $19.83 and its 200-day simple moving average is $21.46. If we look at the stock’s price movements over the week, volatility stands at 5.59%, which increases to 12.46% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 23.02 to suggest the stock is oversold.
The consensus objective for the share price is $59.00, suggesting that the stock has a potential upside of 95.49% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
H.C. Wainwright upgraded the stock to “Buy” from Neutral on October 08, 2024 at a price target of $116.
The current price level is -71.93%, -86.58%, and -87.60% away from its SMA20, SMA50, and SMA200 respectively, with the SAVA price moving above the 50-day SMA on current market day. Cassava Sciences Inc (SAVA) stock is down -9.52% over the week and -89.82% over the past month. Its price is -88.18% year-to-date and -91.17% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.68 and -1.58 for whole year.
To reach the target analysts have set, the stock logically needs to grow 95.49 percent from here.
The company has a return on investment of -10.60% and return on equity of -10.98%. The beta has a value of -1.08. Price to book ratio is 0.77.
